Political Panel - Is MS Therapy a Healthy Risk?

Murray Mandryk joins Stefani to break down the political consequences of funding controversial health studies.  The first Saskatchewan MS patients are preparing to head to New York to be part of teh first double-blind study on the so-called Liberation Therapy. Is funding this clinical trial good PR for Brad Wall? Or could it be risky business?